Homocysteine, a risk factor for atherosclerotic and thromboembolic vascular disease, is higher in patients who have undergone orthotopic cardiac transplantation

被引：0
|
作者：
Moustapha, A [1 ]
Gupta, A [1 ]
Jacobsen, DW [1 ]
Green, R [1 ]
Goormastic, M [1 ]
Tuczu, EM [1 ]
Young, J [1 ]
Hobbs, R [1 ]
James, K [1 ]
Robinson, K [1 ]
机构：
[1] CLEVELAND CLIN FDN,CLEVELAND,OH 44195
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 1997年 / 29卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：99152 / 99152
页数：1
相关论文
共 47 条
  • [41] INCREASED RISK OF CARDIOVASCULAR DISEASE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO HAVE ASYMPTOMATIC PLAQUE ON VASCULAR ULTRASOUND: A 5 YEAR FOLLOW-UP STUDY
    Bakshi, Jyoti
    Rahman, Anisur
    Isenberg, David
    Croca, Sara
    RHEUMATOLOGY, 2017, 56 : 176 - 176
  • [42] Moderate Ascites Identifies Patients With Low Model for End-Stage Liver Disease Scores Awaiting Liver Transplantation Who Have a High Mortality Risk
    Somsouk, Ma
    Kornfield, Rachel
    Vittinghoff, Eric
    Inadomi, John M.
    Biggins, Scott W.
    LIVER TRANSPLANTATION, 2011, 17 (02) : 129 - 136
  • [43] Patients Hospitalized With Acute Decompensated Heart Failure With Reduced Ejection Fraction Who Have Concomitant Peripheral Arterial Disease Have a Higher Risk to Develop Acute Prerenal Kidney Injury: A Nationwide Study
    Haddadin, Faris, I
    Bandyopadhyay, Dhrubajyoti
    Estrella, Alba M.
    Beydoun, Hassan
    Modi, Vivek A.
    Jimenez, Johnassis
    CIRCULATION, 2018, 138
  • [44] The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation
    Szygula-Jurkiewicz, Bozena
    Zakliczynski, Michal
    Andrejczuk, Mariusz
    Moscinski, Mateusz
    Zembala, Marian
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2014, 11 (02): : 178 - 181
  • [45] Neurocognitive and Neurological Outcomes in Children, Adolescents and Young Adults with High Risk Sickle Cell Disease (SCD) Who have Undergone Familial Haploidential (FHI) Allogeneic Stem Cell Transplantation Utilizing CD34 Enrichment and T Cell Addback following Myeloimmunoablative Conditioning (MIC)
    Braniecki, Suzanne
    Talano, Julie-An
    Moore, Theodore B.
    Weinberg, Rona S.
    Keever-Taylor, Carolyn A.
    Grossman, Brenda
    Baxter-Lowe, Lee Ann
    Parsons, Susan K.
    Morris, Erin
    Fabricatore, Sandra
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S100 - S100
  • [46] Stable to Improved Neurocognitive Outcomes in Children, Adolescents & Young Adults with High-Risk Sickle Cell Disease (SCD) Who Have Undergone Familial Haploidentical (Fill) Stem Cell Transplantation: A Prospective Study from Pre HSCT Period to 2 Years Post HSCT (IND 14359)
    Brcudecki, Suzanne
    Moore, Theodore B.
    Talano, Julie-An M.
    Shi, Qiuhu
    Flower, Allyson
    Panarella, Anne
    Fabricatore, Sandra
    Morris, Erin
    Milner, Jordan
    McKinstry, Robert
    Shenoy, Shalini
    Cairo, Mitchell S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S65 - S66
  • [47] MicroRNA-497/fibroblast growth factor-23 axis, a predictive indictor for decreased major adverse cardiac and cerebral event risk in end-stage renal disease patients who underwent continuous ambulatory peritoneal dialysis
    Liu, Dianjun
    Zhou, Silian
    Mao, Huihui
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (06)
12345